27 September 2019 - Deborah Wilkes
Premium
Regulatory agencies around the world are taking action on medicines containing ranitidine after tests showed some contain "low levels" of a probable human carcinogen called N-nitrosodimethylamine (NDMA).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.